143 related articles for article (PubMed ID: 26531778)
1. Ezrin-radixin-moesin-binding phosphoprotein-50 regulates EGF-induced AKT activation through interaction with EGFR and PTEN.
Zheng J; Dai Y; Yang Z; Yang L; Peng Z; Meng R; Xiong Y; He J
Oncol Rep; 2016 Jan; 35(1):530-7. PubMed ID: 26531778
[TBL] [Abstract][Full Text] [Related]
2. EBP50 interacts with EGFR and regulates EGFR signaling to affect the prognosis of cervical cancer patients.
Peng Z; Wang Q; Zhang Y; He J; Zheng J
Int J Oncol; 2016 Oct; 49(4):1737-45. PubMed ID: 27509846
[TBL] [Abstract][Full Text] [Related]
3. EBP50 inhibits EGF-induced breast cancer cell proliferation by blocking EGFR phosphorylation.
Yao W; Feng D; Bian W; Yang L; Li Y; Yang Z; Xiong Y; Zheng J; Zhai R; He J
Amino Acids; 2012 Nov; 43(5):2027-35. PubMed ID: 22476347
[TBL] [Abstract][Full Text] [Related]
4. Loss of EBP50 stimulates EGFR activity to induce EMT phenotypic features in biliary cancer cells.
Clapéron A; Guedj N; Mergey M; Vignjevic D; Desbois-Mouthon C; Boissan M; Saubaméa B; Paradis V; Housset C; Fouassier L
Oncogene; 2012 Mar; 31(11):1376-88. PubMed ID: 21822312
[TBL] [Abstract][Full Text] [Related]
5. EBP50 inhibits the migration and invasion of human breast cancer cells via LIMK/cofilin and the PI3K/Akt/mTOR/MMP signaling pathway.
Li H; Zhang B; Liu Y; Yin C
Med Oncol; 2014 Sep; 31(9):162. PubMed ID: 25119502
[TBL] [Abstract][Full Text] [Related]
6. Breast cancer-derived K172N, D301V mutations abolish Na+/H+ exchanger regulatory factor 1 inhibition of platelet-derived growth factor receptor signaling.
Cheng S; Li Y; Yang Y; Feng D; Yang L; Ma Q; Zheng S; Meng R; Wang S; Wang S; Jiang WG; He J
FEBS Lett; 2013 Oct; 587(20):3289-95. PubMed ID: 24012959
[TBL] [Abstract][Full Text] [Related]
7. The E3 ubiquitin ligase NEDD4 mediates cell migration signaling of EGFR in lung cancer cells.
Shao G; Wang R; Sun A; Wei J; Peng K; Dai Q; Yang W; Lin Q
Mol Cancer; 2018 Feb; 17(1):24. PubMed ID: 29455656
[TBL] [Abstract][Full Text] [Related]
8. Acquired resistance to erlotinib in A-431 epidermoid cancer cells requires down-regulation of MMAC1/PTEN and up-regulation of phosphorylated Akt.
Yamasaki F; Johansen MJ; Zhang D; Krishnamurthy S; Felix E; Bartholomeusz C; Aguilar RJ; Kurisu K; Mills GB; Hortobagyi GN; Ueno NT
Cancer Res; 2007 Jun; 67(12):5779-88. PubMed ID: 17575145
[TBL] [Abstract][Full Text] [Related]
9. Phosphatase and tensin homolog regulates stability and activity of EphB1 receptor.
Rodriguez S; Huynh-Do U
FASEB J; 2013 Feb; 27(2):632-44. PubMed ID: 23118026
[TBL] [Abstract][Full Text] [Related]
10. Molecular aspects of gefitinib antiproliferative and pro-apoptotic effects in PTEN-positive and PTEN-negative prostate cancer cell lines.
Festuccia C; Muzi P; Millimaggi D; Biordi L; Gravina GL; Speca S; Angelucci A; Dolo V; Vicentini C; Bologna M
Endocr Relat Cancer; 2005 Dec; 12(4):983-98. PubMed ID: 16322337
[TBL] [Abstract][Full Text] [Related]
11. A Novel NHERF1 Mutation in Human Breast Cancer Inactivates Inhibition by NHERF1 Protein in EGFR Signaling.
DU G; Hao C; Gu Y; Wang Z; Jiang WG; He J; Cheng S
Anticancer Res; 2016 Mar; 36(3):1165-73. PubMed ID: 26977012
[TBL] [Abstract][Full Text] [Related]
12. Could changes in the regulation of the PI3K/PKB/Akt signaling pathway and cell cycle be involved in astrocytic tumor pathogenesis and progression?
Hlobilkova A; Ehrmann J; Sedlakova E; Krejci V; Knizetova P; Fiuraskova M; Kala M; Kalita O; Kolar Z
Neoplasma; 2007; 54(4):334-41. PubMed ID: 17822324
[TBL] [Abstract][Full Text] [Related]
13. Epidermal growth factor modulates prostate cancer cell invasiveness regulating urokinase-type plasminogen activator activity. EGF-receptor inhibition may prevent tumor cell dissemination.
Festuccia C; Angelucci A; Gravina GL; Biordi L; Millimaggi D; Muzi P; Vicentini C; Bologna M
Thromb Haemost; 2005 May; 93(5):964-75. PubMed ID: 15886816
[TBL] [Abstract][Full Text] [Related]
14. Expression and clinicopathological significance of oestrogen-responsive ezrin-radixin-moesin-binding phosphoprotein 50 in breast cancer.
Song J; Bai J; Yang W; Gabrielson EW; Chan DW; Zhang Z
Histopathology; 2007 Jul; 51(1):40-53. PubMed ID: 17593079
[TBL] [Abstract][Full Text] [Related]
15. Differential roles of ERK and Akt pathways in regulation of EGFR-mediated signaling and motility in prostate cancer cells.
Gan Y; Shi C; Inge L; Hibner M; Balducci J; Huang Y
Oncogene; 2010 Sep; 29(35):4947-58. PubMed ID: 20562913
[TBL] [Abstract][Full Text] [Related]
16. Protein phosphatase 2A PR130/B''alpha1 subunit binds to the SH2 domain-containing inositol polyphosphate 5-phosphatase 2 and prevents epidermal growth factor (EGF)-induced EGF receptor degradation sustaining EGF-mediated signaling.
Zwaenepoel K; Goris J; Erneux C; Parker PJ; Janssens V
FASEB J; 2010 Feb; 24(2):538-47. PubMed ID: 19825976
[TBL] [Abstract][Full Text] [Related]
17. Ezrin-Radixin-Moesin Binding Phosphoprotein 50 (EBP50) Suppresses the Metastasis of Breast Cancer and HeLa Cells by Inhibiting Matrix Metalloproteinase-2 Activity.
Wang L; Qi Y; Xiong Y; Peng Z; Ma Q; Zhang Y; Song J; Zheng J
Anticancer Res; 2017 Aug; 37(8):4353-4360. PubMed ID: 28739728
[TBL] [Abstract][Full Text] [Related]
18. PTEN sensitizes epidermal growth factor-mediated proliferation in endometrial carcinoma cells.
Tang LL; Yokoyama Y; Wan X; Iwagaki S; Niwa K; Tamaya T
Oncol Rep; 2006 Apr; 15(4):855-9. PubMed ID: 16525671
[TBL] [Abstract][Full Text] [Related]
19. P53 and PTEN expression contribute to the inhibition of EGFR downstream signaling pathway by cetuximab.
Bouali S; Chrétien AS; Ramacci C; Rouyer M; Marchal S; Galenne T; Juin P; Becuwe P; Merlin JL
Cancer Gene Ther; 2009 Jun; 16(6):498-507. PubMed ID: 19165235
[TBL] [Abstract][Full Text] [Related]
20. EGF‑stimulated AKT activation is mediated by EGFR recycling via an early endocytic pathway in a gefitinib‑resistant human lung cancer cell line.
Nishimura Y; Takiguchi S; Ito S; Itoh K
Int J Oncol; 2015 Apr; 46(4):1721-9. PubMed ID: 25653196
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
